Laboratory Medicine ›› 2018, Vol. 33 ›› Issue (8): 768-769.DOI: 10.3969/j.issn.1673-8640.2018.08.022
• Orginal Article • Previous Articles Next Articles
Received:2018-02-28
Online:2018-08-30
Published:2018-09-07
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2018.08.022
| 组别 | 例数 | CEA（ng/mL） | HE4（pmol/L） |
|---|---|---|---|
| 恶性胸腔 积液组 | 126 | 44.43 （5.23~387.30）* | 2 250.50 （795.22~3 555.00）* |
| 良性胸腔 积液组 | 120 | 1.08 （0.55~2.41） | 252.75 （132.27~569.50） |
| 组别 | 例数 | CEA（ng/mL） | HE4（pmol/L） |
|---|---|---|---|
| 恶性胸腔 积液组 | 126 | 44.43 （5.23~387.30）* | 2 250.50 （795.22~3 555.00）* |
| 良性胸腔 积液组 | 120 | 1.08 （0.55~2.41） | 252.75 （132.27~569.50） |
| 项目 | AUC （95%可信区间） | 标准误 | P值 | 约登 指数 |
|---|---|---|---|---|
| CEA | 0.836（0.783~0.888） | 0.027 | 0.000 | 0.604 |
| HE4 | 0.864（0.818~0.910） | 0.023 | 0.000 | 0.621 |
| CEA+HE4 | 0.908（0.871~0.946） | 0.019 | 0.000 | 0.715 |
| 项目 | AUC （95%可信区间） | 标准误 | P值 | 约登 指数 |
|---|---|---|---|---|
| CEA | 0.836（0.783~0.888） | 0.027 | 0.000 | 0.604 |
| HE4 | 0.864（0.818~0.910） | 0.023 | 0.000 | 0.621 |
| CEA+HE4 | 0.908（0.871~0.946） | 0.019 | 0.000 | 0.715 |
| [1] | BARBIERI R L.In women who have a pelvic mass. Have you tried this new ovarian Ca biomarker?[J]. OBG Management,2010,22(4):8-12. |
| [2] | 应海平. 胸水ADA和CEA检测在胸腔积液中的鉴别诊断价值[J]. 现代实用医学,2006,18(6):390. |
| [3] | 刘娟,刘纯,彭林. 多种肿瘤标志物联合检测在良恶性胸水中的诊断价值[J]. 医学临床研究,2007,24(3):469-471. |
| [4] | MOORE R G,HILL E K,HORAN T,et al.HE4(WFDC2) gene overexpression promotes ovarian tumor growth[J]. Sci Rep,2014,4:3574. |
| [5] | 肖然,胡昊昀,王瑞,等. 血清肿瘤标志物HE4检测在肺癌诊断中的应用价值探讨[J]. 检验医学,2014,29(9):893-896. |
| [6] | ZENG Q,LIU M,ZHOU N,et al.Serum human epididymis protein 4(HE4) may be a better tumor marker in early lung cancer[J]. Clin Chim Acta,2016,455:102-106. |
| [7] | KAMEI M,YAMASHITA S,TOKUISHI K,et al.HE4 expression can be associated with lymph node metastases and disease-free survival in breast cancer[J]. Anticancer Res,2010,30(11):4779-4783. |
| [8] | XI Z,LINLIN M,YE T.Human epididymis protein 4 is a biomarker for transitional cell carcinoma in the urinary system[J]. J Clin Lab Anal,2009,23(6):357-361. |
| [9] | IWAHORI K,SUZUKI H,KISHI Y,et al.Serum HE4 as a diagnostic and prognostic marker for lung cancer[J]. Tumour Biol,2012,33(4):1141-1149. |
| [1] | FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114. |
| [2] | SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120. |
| [3] | LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129. |
| [4] | YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140. |
| [5] | XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146. |
| [6] | CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152. |
| [7] | . [J]. Laboratory Medicine, 2023, 38(12): 1153-1156. |
| [8] | . [J]. Laboratory Medicine, 2023, 38(12): 1157-1159. |
| [9] | WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166. |
| [10] | YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172. |
| [11] | DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176. |
| [12] | GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182. |
| [13] | . [J]. Laboratory Medicine, 2023, 38(12): 1183-1185. |
| [14] | . [J]. Laboratory Medicine, 2023, 38(12): 1186-1190. |
| [15] | . [J]. Laboratory Medicine, 2023, 38(12): 1191-1194. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
